PTGS2 and cancer: Among the proinflammatory factors involved in tumor progression, cyclooxygenase-2 (COX2) and its product prostaglandin E2 (PGE2) have been found to be upregulated in many cancer types, favoring cell growth and survival and contributing to the generation of an immune suppressive TME [17].